Novavax (NVAX) has recently seen a decrease in stock value, dropping after announcing Q4 results that missed revenue expectations. The company ...
15h
News Medical on MSNStudy shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetesKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.
FDA nominee Marty Makary pledges to review the cancellation of a key flu vaccine meeting, addressing concerns over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results